Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Blood

• Publication date

  1983-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V62.2.327.BLOODJOURNAL622327PMID 6409188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and lectins from Ricinus communis by combination of affinity and ion-exchange chromatography and characterization of the isolated proteins.

  1982cited by this paper
• Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity

  1982cited by this paper
• Neoplastic B Cells as Targets for Antibody‐Ricin A Chain Immunotoxins

  1982cited by this paper
• Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate

  1982cited by this paper
• Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation

  1982cited by this paper
• AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

  1982cited by this paper
• Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin

  1982cited by this paper
• Studies on the clonal origin of human B cell leukemia using monoclonal anti-idiotype antibodies.

  1982cited by this paper
• In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

  1982cited by this paper
• Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.

  1982cited by this paper
• Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates

  1982cited by this paper
• Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells.

  1981cited by this paper
• Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

  1981cited by this paper
• Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

  1980cited by this paper
• The influence of culture conditions on the production of colony-stimulating activity by human placenta.

  1980cited by this paper
• Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.

  1979cited by this paper
• Homology between ricin and Ricinus communis agglutinin: amino terminal sequence analysis and protein synthesis inhibition studies.

  1978cited by this paper
• Differential counts of neutrophil, eosinophil, and macrophage colonies in cultures from human bone marrow and peripheral blood

  1978cited by this paper
• Selection and characterization of cells resistant to diphtheria toxin and pseudomonas exotoxin A: presumptive translational mutants.

  1977cited by this paper
• Normal Human Bone Marrow Cultures in Vitro: Cellular Composition and Maturation of the Granulocytic Colonies

  1977cited by this paper
• Cell surface immunoglobulin. XXII. Reappearance of surface IgM and IgD on murine splenocytes after removal by capping.

  1977cited by this paper
• An efficient mRNA-dependent translation system from reticulocyte lysates.

  1976cited by this paper
• Cell surface immunoglobulin. XVIII. Functional differences of B lymphocytes bearing different surface immunoglobulin isotypes

  1976cited by this paper
• Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E.

  1974cited by this paper
• Isolation of 7S IgM and kappa chains from the surface membrane of tissue culture cells derived from a Burkitt lymphoma.

  1971cited by this paper
• The continued requirement for inducer for the development of macrophage and granulocyte colonies

  1968cited by this paper
• Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

  1968cited by this paper

• PDF hosted at the Radboud Repository of the Radboud University Nijmegen

  2017influential citation
• Ribosome-Inactivating Proteins from Plants: A Historical Overview

  2016cites this paper
• Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform

  2014cites this paper
• Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies

  2012cites this paper
• A Ribosome-inactivating Protein Toxin as a Template for Cancer Drug Discovery

  2012cites this paper
• Immunotoxins for targeted cancer therapy

  2006cites this paper
• Preclinical Assessments of 90 Y-labeledC 110 Anti-Carcinoembryonic Antigen Immunotoxin : A Therapeutic Immunoconjugate for Human Colon Cancer 1

  2006cites this paper
• Immunotoxins in the treatment of hematologic malignancies.

  2006cites this paper
• An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells

  2004cites this paper
• Use of a Novel Colony Assay to Evaluate

  2003cites this paper
• Autologous stem cell transplantation and purging in adult acute lymphoblastic leukaemia.

  2002cites this paper
• Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?

  2002cites this paper
• Immunotoxins for targeted cancer therapy.

  1998cites this paper
• Ex Vivo Breast Cancer Cell Purging by Adenovirus-Mediated Cytosine Deaminase Gene Transfer and Short-Term Incubation with 5-Fluorocytosine Completely Prevents Tumor Growth after Transplantation

  1998cites this paper
• Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.

  1997cites this paper
• Molecular genetics and lymphoproliferative disorders

  1996cites this paper
• CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy.

  1995cites this paper
• In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells.

  1995cites this paper
• Bone Marrow Purging in Acute Lymphoblastic Leukemia: Biological and Clinical Features

  1994cites this paper
• Ribosome-inactivating proteins from plants.

  1993cites this paper
• Concepts of antibody-mediated cancer therapy.

  1993cites this paper
• Techniques of harvesting and cryopreservation of stem cells.

  1993cites this paper
• Efficacy of an anti-CD5-ricin A chain immunoconjugate in an improved human peripheral blood lymphocyte--reconstituted severe combined immunodeficient mouse model.

  1993cites this paper
• Non-Hodgkin's lymphomas in children. II. Treatment.

  1992cites this paper
• Quantitation of Tumor Cell Removal from Bone Marrow: A Preclinical Model

  1992cites this paper
• Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.

  1992cites this paper
• Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.

  1991cites this paper
• Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through device.

  1991cites this paper
• Bone marrow transplantation

  1991cites this paper
• Clinical Use of Immunotoxins

  1991cites this paper
• Targeted killing of yeast expressing a HIV-1 peptide by antibody-conjugated glucose oxidase and horseradish peroxidase.

  1990cites this paper
• Tumour cell purging for autologous bone marrow transplantation.

  1990cites this paper
• Cytotoxicity of glucose oxidase conjugated with antibodies to target cells: killing efficiency depends on the conjugate internalization.

  1990cites this paper
• Bone marrow transplantation for solid tumors in pediatrics.

  1990cites this paper
• Bone marrow transplantation in acute lymphoblastic leukemia.

  1990cites this paper
• Antilymphocyte Antibodies: Polyclonal and Monoclonal

  1989cites this paper
• Malignant leukemic cell separation by iron colloid immunomagnetic adsorption.

  1989cites this paper
• Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates.

  1989cites this paper
• Immunological aspects of toxicology: premises not promises.

  1989cites this paper
• Recombinant alpha-interferon as salvage therapy in multiple myeloma. A pilot study.

  1989cites this paper
• 18. Bone Marrow Purging

  1989cites this paper
• Modifications of Monoclonal Antibody for Immunotherapy

  1989cites this paper
• Monoclonal Antibodies

  1989cites this paper
• Bone Marrow Purging

  1989cites this paper
• Immunotherapy of Disease

  1989cites this paper
• Effects of an anti HLA-DR immunotoxin on leukaemia cells and hematopoietic progenitors.

  1989cites this paper
• Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell‐associated antigens: Effects on target cells and on normal myeloid precursors (CFU‐GM)

  1989cites this paper
• Specific killing of human endothelial cells by antibody-conjugated glucose oxidase.

  1988cites this paper
• Different Susceptibilities of Normal T Cells and T Cell Lines to Immunotoxins

  1988cites this paper
• Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

  1988cites this paper
• Is Transformed Bone Marrow Cell Line a Substitute for Normal Bone Marrow Cells in Laser Photoradiation Therapy for Bone Marrow Purging

  1988cites this paper
• Toxicity of monoclonal antibodies in the treatment of cancer.

  1988cites this paper
• Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.

  1988cites this paper
• Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.

  1988cites this paper
• Immunotoxins: properties, applications and current limitations

  1988cites this paper
• Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.

  1988cites this paper
• Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.

  1988cites this paper
• Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells.

  1988cites this paper
• Protein A vectorized toxins--II. Preparation and "in vitro" cytotoxic effect of protein A-ricin A chain conjugate on antibody coated human tumour cells.

  1988cites this paper
• Use of a liquid cell culture assay to quantify the elimination of Burkitt lymphoma cells from the bone marrow.

  1987cites this paper
• Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.

  1987cites this paper
• The Use of Ricin a Chain-Containing Immunotoxins to Kill Neoplastic B Cells

  1987cites this paper
• MONOCLONAL ANTIBODY‐RICIN CONJUGATE CYTOTOXIC TO CELLS EXPRESSING THE COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA)

  1987cites this paper
• Nanoparticles in drug delivery.

  1987cites this paper
• Immunotoxins and Endocytosis

  1987cites this paper
• The design of cytotoxic-agent-antibody conjugates.

  1987cites this paper
• Treatment, Treatment Failure and Future Possibilities

  1987cites this paper
• Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.

  1986cites this paper
• A simplified microassay for inhibition of protein synthesis in reticulocyte lysates by immunotoxins.

  1986cites this paper
• Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.

  1986cites this paper
• Evaluation of ricin A-chain immunotoxins directed against human T cells.

  1986cites this paper
• Autologous bone marrow transplantation in haematologic malignancies.

  1986cites this paper
• Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557).

  1986cites this paper
• Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.

  1986cites this paper
• Synergy between immunotoxins prepared with native ricin A chains and chemically-modified ricin B chains.

  1986cites this paper
• Monoclonal antibodies in oncology.

  1986cites this paper
• Determination of sensitivity of fresh leukemia cells to immunotoxins.

  1986cites this paper
• Antigenic modulation by anti-CD5 immunotoxins.

  1986cites this paper
• Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

  1986cites this paper
• RECONSTITUTION OF HEMATOPOIESIS AFTER BONE MARROW PURGING WITH RICIN A CHAIN IMMUNOTOXIN

  1986cites this paper
• Selective Killing of Normal and Neoplastic Human B Cells with Anti-CD 19- and Anti-CD22-Ricin A Chain Immunotoxins

  1986cites this paper
• The current status of monoclonal antibodies in the diagnosis and therapy of cancer.

  1986cites this paper
• [Means of increasing the effectiveness of drug therapy of malignant neoplasms].

  1986cites this paper
• Reactivity of rat monoclonal antibody CAMPATH‐1 with human leukaemia cells and its possible application for autologous bone marrow transplantation

  1985cites this paper
• Adult T cell leukemia: a potential target for ricin A chain immunotoxins.

  1985cites this paper
• Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.

  1985cites this paper
• Antibody-toxin hybrids: a clinical review of their use.

  1985cites this paper
• Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.

  1985cites this paper
• A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro.

  1985cites this paper
• Advances in the applications of monoclonal antibodies in clinical oncology. University of London Royal Postgraduate Medical School. 8th-10th May, 1985. Abstracts.

  1985cites this paper
• Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement.

  1985cites this paper
• Chronic myelogenous leukemia: is aggressive treatment indicated?

  1985cites this paper
• Immunotoxins Containing Ricin A Or B Chains with Modified Carbohydrate Residues Act Synergistically in Killing Neoplastic B Cells In Vitro*

  1985cites this paper
• Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin.

  1985cites this paper
• Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.

  1985cites this paper
• Peptides and Proteins as Drugs

  1985cites this paper
• Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein.

  1985cites this paper
• Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis.

  1985cites this paper
• Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.

  1985cites this paper
• Acute lymphoblastic leukemia in adults.

  1985cites this paper